Catalent, Inc.
CTLTDelisted Dec 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596783
Catalent, Inc. was delisted on Dec 18, 2024; its insiders filed their last Form 4 on Dec 18, 2024; 472 institutions reported holding it in 13F filings for Q3 2024, worth $10.8B in total; Elliott Investment Management was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Catalent, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 528 | 3 | 443 | −82 |
| Shares | 189.6M | 192.8K | 201.0M | +11.5M (+6.1%) |
| Value | $12.5B | $12.7M | $8.72B | −$3.72B (−29.9%) |
3 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (61)
Institutions that held Catalent, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (143)
Institutions that held Catalent, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
Showing the largest 100 of 143 by value.
Not filed for Q2 2023 yet (3)
Institutions that held Catalent, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Davidson Kempner Partners | 185,000 | $12.2M |
| Avalon Investment & Advisory | 7,772 | $510.7K |
| Pathway Financial Advisers, LLC | 64 | $4.21K |